These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 38846358)

  • 41. Antigenic divergence between Bordetella pertussis clinical isolates from Moscow, Russia, and vaccine strains.
    Borisova O; Kombarova SY; Zakharova NS; van Gent M; Aleshkin VA; Mazurova I; Mooi FR
    Clin Vaccine Immunol; 2007 Mar; 14(3):234-8. PubMed ID: 17202309
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emergence of pertactin-deficient pertussis strains in Australia can be explained by models of vaccine escape.
    Jayasundara D; Lee E; Octavia S; Lan R; Tanaka MM; Wood JG
    Epidemics; 2020 Jun; 31():100388. PubMed ID: 32387895
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis.
    Cherry JD; Heininger U; Richards DM; Storsaeter J; Gustafsson L; Ljungman M; Hallander HO
    Clin Vaccine Immunol; 2010 May; 17(5):741-7. PubMed ID: 20335431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Establishment of Ph. Eur. Bordetella pertussis mouse antiserum Biological Reference Preparation batches 2, 3 and 4.
    Morgeaux S; Chagnaud P; Variot P; Le Tallec D; Behr-Gross ME
    Pharmeur Bio Sci Notes; 2020; 2020():161-202. PubMed ID: 32788038
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New Data on Vaccine Antigen Deficient Bordetella pertussis Isolates.
    Bouchez V; Hegerle N; Strati F; Njamkepo E; Guiso N
    Vaccines (Basel); 2015 Sep; 3(3):751-70. PubMed ID: 26389958
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pertactin-Deficient Bordetella pertussis with Unusual Mechanism of Pertactin Disruption, Spain, 1986-2018.
    Mir-Cros A; Moreno-Mingorance A; Martín-Gómez MT; Abad R; Bloise I; Campins M; González-Praetorius A; Gutiérrez MN; Martín-González H; Muñoz-Almagro C; Orellana MÁ; de Pablos M; Roca-Grande J; Rodrigo C; Rodríguez ME; Uriona S; Vidal MJ; Pumarola T; Larrosa MN; González-López JJ
    Emerg Infect Dis; 2022 May; 28(5):967-976. PubMed ID: 35447067
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Pertussis Outer Membrane Vesicle-Based Vaccine Induces Lung-Resident Memory CD4 T Cells and Protection Against
    Zurita ME; Wilk MM; Carriquiriborde F; Bartel E; Moreno G; Misiak A; Mills KHG; Hozbor D
    Front Cell Infect Microbiol; 2019; 9():125. PubMed ID: 31106160
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The global prevalence ptxP3 lineage of Bordetella pertussis was rare in young children with the co-purified aPV vaccination: a 5 years retrospective study.
    Wang Z; Luan Y; Du Q; Shu C; Peng X; Wei H; Hou T; Liu Y; Liu X; Li Y
    BMC Infect Dis; 2020 Aug; 20(1):615. PubMed ID: 32814558
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bordetella pertussis isolates in Finland after acellular vaccination: serotype change and biofilm formation.
    Niinikoski V; Barkoff AM; Mertsola J; He Q
    Clin Microbiol Infect; 2024 May; 30(5):683.e1-683.e3. PubMed ID: 38310999
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genomic epidemiology of erythromycin-resistant Bordetella pertussis in China.
    Xu Z; Wang Z; Luan Y; Li Y; Liu X; Peng X; Octavia S; Payne M; Lan R
    Emerg Microbes Infect; 2019; 8(1):461-470. PubMed ID: 30898080
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Colonization of Bordetella pertussis clinical isolates that differ by pulsed field gel electrophoresis types in the lungs of naïve mice or mice immunized with the whole-cell pertussis vaccine used in Poland.
    Polak M; Zawadka M; Mosiej E; Rabczenko D; Augustynowicz E; Guiso N; Lutyńska A
    Arch Immunol Ther Exp (Warsz); 2015 Apr; 63(2):155-60. PubMed ID: 25297678
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The evolving nature of
    Tsang RSW; Shuel M; Cronin K; Deng S; Whyte K; Marchand-Austin A; Ma J; Bolotin S; Crowcroft N; Schwartz K; Van Domselaar G; Graham M; Jamieson FB
    Can J Microbiol; 2019 Nov; 65(11):823-830. PubMed ID: 31295416
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pertactin-Deficient Bordetella pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis.
    Ma L; Caulfield A; Dewan KK; Harvill ET
    Emerg Infect Dis; 2021 Jun; 27(6):1561-1566. PubMed ID: 34014152
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs.
    Hallander HO; Advani A; Donnelly D; Gustafsson L; Carlsson RM
    J Clin Microbiol; 2005 Jun; 43(6):2856-65. PubMed ID: 15956409
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibody responses to individual Bordetella pertussis fimbrial antigen Fim2 or Fim3 following immunization with the five-component acellular pertussis vaccine or to pertussis disease.
    Alexander F; Matheson M; Fry NK; Labram B; Gorringe AR
    Clin Vaccine Immunol; 2012 Nov; 19(11):1776-83. PubMed ID: 22956654
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bordetella pertussis vaccine strains and circulating isolates in Serbia.
    Dakic G; Kallonen T; Elomaa A; Pljesa T; Vignjevic-Krastavcevic M; He Q
    Vaccine; 2010 Feb; 28(5):1188-92. PubMed ID: 19945417
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence and characterization of pertactin deficient
    Leite D; Camargo CH; Kashino SS; Polatto R; Martins LM; Pereira JC; Pawloski L; Tondella ML; Oliveira RS; Vaz de Lima LRA
    Vaccine X; 2021 Aug; 8():100103. PubMed ID: 34179765
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evolution of Bordetella pertussis in the acellular vaccine era in Norway, 1996 to 2019.
    Brandal LT; Vestrheim DF; Bruvik T; Roness RB; Bjørnstad ML; Greve-Isdahl M; Steens A; Brynildsrud OB
    Eur J Clin Microbiol Infect Dis; 2022 Jun; 41(6):913-924. PubMed ID: 35543837
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genomic epidemiology and multilevel genome typing of
    Payne M; Xu Z; Hu D; Kaur S; Octavia S; Sintchenko V; Lan R
    Emerg Microbes Infect; 2023 Dec; 12(2):2239945. PubMed ID: 37483082
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical characteristics, molecular epidemiology and antimicrobial susceptibility of pertussis among children in southern China.
    Zhang JS; Wang HM; Yao KH; Liu Y; Lei YL; Deng JK; Yang YH
    World J Pediatr; 2020 Apr; 16(2):185-192. PubMed ID: 31493136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.